HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shinji Yamamoto Selected Research

Valosin Containing Protein

11/2005Increased expression of valosin-containing protein (p97) is correlated with disease recurrence in follicular thyroid cancer.
8/2004Expression level of valosin-containing protein (p97) is associated with prognosis of esophageal carcinoma.
7/2004Expression level of valosin-containing protein (p97) is correlated with progression and prognosis of non-small-cell lung carcinoma.
5/2004Elevated expression of valosin-containing protein (p97) is associated with poor prognosis of prostate cancer.
2/2004Increased expression of valosin-containing protein (p97) is associated with lymph node metastasis and prognosis of pancreatic ductal adenocarcinoma.
1/2004Expression of valosin-containing protein in colorectal carcinomas as a predictor for disease recurrence and prognosis.
1/2004Valosin-containing protein (p97) and Ki-67 expression is a useful marker in detecting malignant behavior of pancreatic endocrine neoplasms.
7/2003Expression level of valosin-containing protein is strongly associated with progression and prognosis of gastric carcinoma.
2/2003Elevated expression of valosin-containing protein (p97) in hepatocellular carcinoma is correlated with increased incidence of tumor recurrence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shinji Yamamoto Research Topics

Disease

17Neoplasms (Cancer)
10/2020 - 02/2003
8Neoplasm Metastasis (Metastasis)
10/2020 - 02/2003
6Demyelinating Diseases (Demyelinating Disease)
11/2020 - 10/2014
4Multiple Sclerosis
02/2018 - 10/2014
4Ischemic Stroke
01/2010 - 04/2006
4Carcinoma (Carcinomatosis)
07/2007 - 07/2003
3Spinal Cord Diseases
12/2016 - 01/2014
3Colorectal Neoplasms (Colorectal Cancer)
08/2012 - 01/2004
3Hepatocellular Carcinoma (Hepatoma)
02/2006 - 02/2003
3Lymphatic Metastasis
01/2006 - 02/2004
2Neuroinflammatory Diseases
12/2021 - 10/2017
2Prostatic Neoplasms (Prostate Cancer)
03/2020 - 05/2004
2Ischemia
01/2017 - 10/2014
2Hemorrhage
06/2009 - 08/2002
2Hyperplasia
03/2005 - 09/2002
2Adenocarcinoma
02/2004 - 01/2004
1Macular Degeneration (Age-Related Maculopathy)
05/2022
1Myopia
05/2022
1Osteoarthritis
10/2020
1Disease Progression
03/2020
1Communicable Diseases (Infectious Diseases)
12/2019
1Partial Epilepsies (Epilepsy, Partial)
11/2019
1Impetigo (Impetigo Contagiosa)
04/2019
1Muscle Tissue Neoplasms
11/2018
1Hyperalgesia
02/2018
1Neuralgia (Stump Neuralgia)
02/2018
1Peripheral Nerve Injuries
02/2018
1Pain (Aches)
02/2018
1Weight Loss (Weight Reduction)
10/2017
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2017
1Neutropenia
12/2016
1Spinal Cord Compression
12/2016
1Subacute Combined Degeneration
10/2016
1Ectopic Pregnancy
01/2016
1Nocturia
03/2015
1Lower Urinary Tract Symptoms
03/2015
1Leukopenia
10/2014
1Thrombocytosis (Thrombocythemia)
10/2014
1Triple Negative Breast Neoplasms
10/2014
1Hypertension (High Blood Pressure)
08/2014

Drug/Important Bio-Agent (IBA)

9Valosin Containing ProteinIBA
11/2005 - 02/2003
6CuprizoneIBA
11/2020 - 10/2014
6NF-kappa B (NF-kB)IBA
08/2004 - 02/2003
4Proteins (Proteins, Gene)FDA Link
12/2021 - 01/2004
3Phosphatidic Acids (Phosphatidic Acid)IBA
10/2020 - 10/2014
3DNA (Deoxyribonucleic Acid)IBA
11/2018 - 11/2004
3CytokinesIBA
10/2017 - 11/2004
3Pharmaceutical PreparationsIBA
10/2014 - 03/2012
3Tissue Plasminogen Activator (Alteplase)FDA Link
01/2010 - 09/2007
3hepatoma-derived growth factorIBA
07/2007 - 01/2006
3Indicators and Reagents (Reagents)IBA
01/2004 - 02/2003
2Prostate-Specific Antigen (Semenogelase)IBA
03/2020 - 05/2004
2Nerve Growth Factors (Neurotrophins)IBA
01/2017 - 10/2014
2Neuroprotective AgentsIBA
12/2016 - 01/2014
2Yttrium-90IBA
08/2012 - 07/2009
2Capsules (Microcapsules)IBA
01/2012 - 08/2002
2EnzymesIBA
11/2004 - 01/2004
2Fluorouracil (Carac)FDA LinkGeneric
10/2004 - 08/2004
1Glucagon-Like Peptide 1 (GLP 1)IBA
12/2021
1LipidsIBA
12/2021
1LiraglutideFDA Link
12/2021
1ProstaglandinsIBA
12/2021
1Prostaglandin D2IBA
12/2021
1Insulin-Like Growth Factor I (IGF-1)IBA
11/2020
1Ursolic AcidIBA
11/2020
1LysophospholipidsIBA
10/2020
1bicalutamide (Casodex)FDA LinkGeneric
03/2020
1AndrogensIBA
03/2020
1Flutamide (Eulexin)FDA LinkGeneric
03/2020
1enzalutamideIBA
03/2020
1Antiviral Agents (Antivirals)IBA
12/2019
1PhytochemicalsIBA
12/2019
1TeaIBA
12/2019
1Anticonvulsants (Antiepileptic Drugs)IBA
11/2019
1perampanelIBA
11/2019
1Anti-Bacterial Agents (Antibiotics)IBA
04/2019
1cyclic phosphatidic acid 16:0IBA
02/2018
1lysophosphatidic acidIBA
02/2018
1Lysophosphatidic Acid ReceptorsIBA
02/2018
1baicaleinIBA
10/2017
1FlavonoidsIBA
10/2017
12-carba-cyclic phosphatidic acidIBA
01/2017
1InflammasomesIBA
01/2017
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2016
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
10/2016
1ZincIBA
10/2016
1CopperIBA
10/2016
1naftopidilIBA
03/2015
1Protein Kinases (Protein Kinase)IBA
10/2014
1Antihypertensive Agents (Antihypertensives)IBA
08/2014
1CreatinineIBA
08/2014

Therapy/Procedure

8Therapeutics
03/2020 - 08/2004
3Liver Transplantation
03/2011 - 11/2007
2Kidney Transplantation
01/2016 - 08/2002
2Transplantation
09/2012 - 11/2007
2Radioimmunotherapy
08/2012 - 07/2009
2Contraindications
03/2011 - 06/2009
1Traction
05/2022
1Oral Administration
11/2020
1Castration
03/2020